Goldman Sachs Group »

Elicio Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $618k 58k 10.69

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Tesla CMN (TSLA)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN (HYG)
Taiwan Semiconductor Manufac CMN (TSM)

View all positions for Goldman Sachs Group

Top funds holding Elicio Therapeutics

Knoll Capital Management
Vanguard Capital Management
Vanguard Group
Sio Capital Management
Balyasny Asset Management
Geode Capital Management
Marshall Wace
Jane Street
Millennium Management
Citadel Advisors
Vanguard Fiduciary Trust
Susquehanna International
Goldman Sachs Group
683 Capital Management
Northern Trust

View all funds holding Elicio Therapeutics